Not sure what to take away from today's news. It's great to see that they are making strides, but is this news issued purely for the sake of Gerald getting his bonus? I'm in agreement with some of the others here that we need specific Lympro numbers and revenue guidance before this really starts moving. Hate to say it, but todays pr seems a bit of "fluff" to me.